Publisher
Springer Berlin Heidelberg
Reference28 articles.
1. Braun-Falco O, Fröschl M, Gürtler L, Landthaler M et al. (1988) Dermato-venerologische Erkrankungen als Indikatoren für Diagnose und Prognose der HIV-Infektionen. Münch Med Wschr 130: 331–336
2. Brockmeyer NH, Mertins L, Maleßa R, Biniek R, Goos M (1989) Regression of Kaposi’s sarcoma and improvement of performance status by a combined interferone β and zidovudine therapy in AIDS patients. J Invest Dermatol 93: 544
3. Dover JS, Johnson RA (1991) Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol 127: 1383–1391
4. Farthing CF, Brown SE, Staughton RC (1989) A colour atlas of AIDS and HIV disease. 2. Aufl., Editiones Roche, Basel
5. Fischl MA, Uttamchandani RB, Resnick L, Agarwal R, Fletcher MA, Patrone-Reese J, Dearmas L, Chidekel J, McCann M, Myers M (1991) A phase I study of recombinant human interferone-αn1 and concomitant zidovudine in patients with AIDS-related Kaposi’s Sarcoma. Journal of Acquired Immune Deficiency Syndromes 4: 1–10